Tailoring Tumor Cell Golgi Apparatus‐Targeting Self‐Assembled Peptide for Effective Immunotherapy via Reshaping MIF‐Mediated Immunosuppressive Network
Advanced Science · 2025
DOI: 10.1002/advs.202415133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Xiang Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening & Guangdong-Hongkong-M…. Hauptthemen laut MEDLINE: Immunotherapy, Macrophage Migration-Inhibitory Factors, Golgi Apparatus, Breast Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Guangzhou Science and Technology Bureau.
Abstract (Originalsprache)
The immunosuppressive network formed by the enhanced crosstalk between tumor cells and various types of immune cells may ultimately lead to the formation of tumor immunosuppressive microenvironment (TIME). The Golgi apparatus (GA) of tumor cells is a key organelle in the formation of a tumor immunosuppressive network. However, there are no studies to show whether interfering with the GA of tumor cells can reshape the immunosuppressive network to enhance the effectiveness of immunotherapy. Therefore, the tumor cell GA‐targeting self‐assembled peptide (NF‐1) is tailored, and confirmed that NF‐1 treatment can achieve an effective immunotherapy and found that tumor cell‐derived GA‐dependent migration inhibitory factor (MIF) mediates the formation of immunosuppressive network in breast cancer (BRCA) through multi‐omics analysis, in vivo, and in vitro experiments. NF‐1 treatment‐induced MIF reduction can reshape the immunosuppressive network and convert a “cold” tumor into a “hot” tumor, thus enabling immunotherapy in BRCA and enhancing the ICB efficacy in colon adenocarcinoma (COAD). This study presents a general strategy for interfering with tumor GA for effective immunotherapy in BRCA, COAD, and other cancers characterized by a “cold” immune microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening & Guangdong-Hongkong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical…
- Department of Ultrasonic Diagnosis & Orthopedic and Traumatology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510 515, P. R. China.
- Department of Pathophysiology, Guangdong Provincial Key Laboratory of Proteomics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510 515, P. R. China.
- Biomaterials Research Center, School of Biomedical Engineering, Southern Medical University, Guangzhou, 510 515, P. R. China.
- Key Laboratory of Mental Health of the Ministry of Education, Southern Medical University, Guangzhou, 510 515, P. R. China.
ORCID-Profile: Dongfang Zhou
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Guangzhou Science and Technology Bureau
Zitieren
APA
Li, X., Wang, C., Liu, J., Deng, G., Deng, Y., Hu, F., Wang, Y., & Zhou, D. (2025). Tailoring Tumor Cell Golgi Apparatus‐Targeting Self‐Assembled Peptide for Effective Immunotherapy via Reshaping MIF‐Mediated Immunosuppressive Network. Advanced Science. https://doi.org/10.1002/advs.202415133
Vancouver
Li X, Wang C, Liu J, Deng G, Deng Y, Hu F, et al. Tailoring Tumor Cell Golgi Apparatus‐Targeting Self‐Assembled Peptide for Effective Immunotherapy via Reshaping MIF‐Mediated Immunosuppressive Network. Advanced Science. 2025. doi:10.1002/advs.202415133
BibTeX
@article{Li2025,
author = {Li, Xiang and Wang, Chengxinqiao and Liu, Junhan and Deng, Guifang and Deng, Yongqiang and Hu, Fang and Wang, Yupeng and Zhou, Dongfang},
title = {Tailoring Tumor Cell Golgi Apparatus‐Targeting Self‐Assembled Peptide for Effective Immunotherapy via Reshaping MIF‐Mediated Immunosuppressive Network},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202415133}
}
EUVIMED